Product Description
Take advantage of this top-rated Ranitidine HCL IP, engineered to achieve optimum purity and efficacy. Complying with IP requirements, its extraordinary characteristics include a purity of 98.0%-102.0% (on dried basis), related substances NMT 0.5%, and strict adherence to residual solvent and microbial limit specifications. This distinguished white to pale yellow crystalline powder is ideal for the treatment of ulcers and GERD. Packaged in a robust 25 kg fibre drum with double polythene bags, it ensures enduring quality, provided storage instructions are followed. Last chance to secure this highly sought-after API at exceptional value from a leading Indian supplier.
Applications & Usage Scope of Ranitidine HCL IP
Ranitidine HCL IP is a versatile bulk drug, widely used in the pharmaceutical industry for the manufacture of oral dosage forms, emphasizing its role in managing stomach ulcers and gastroesophageal reflux disease (GERD). Beyond its principal applications, it is often integrated into research and development projects focusing on histamine-2 blocker therapies. Both large-scale production and small batch compounding benefit from its standardized particle size and reliable solubility profile.
Sample Policy, Delivery Time, and Packaging Details
Samples of Ranitidine HCL IP are provided under a clear Valuation policy and at the lowest price for domestic market evaluation. Typical delivery times are swift, aligning with supply chain commitments across India. Packaged with the utmost care in sturdy 25 kg fibre drums lined with double polythene bags, each batch is shielded against moisture and physical damage to maintain exceptional quality throughout transportation and storage.
FAQ's of Ranitidine HCL IP:
Q: How should Ranitidine HCL IP be stored to maintain its quality?
A: Ranitidine HCL IP should be stored in a cool, dry place, protected from light, moisture, and physical damage to preserve its integrity throughout its 5-year shelf life.
Q: What are the primary pharmaceutical applications of Ranitidine HCL IP?
A: Ranitidine HCL IP is primarily used for the treatment of ulcers and gastroesophageal reflux disease (GERD), and is commonly manufactured into oral dosage formulations.
Q: When can I expect delivery after placing an order for Ranitidine HCL IP?
A: Delivery times are typically fast and tailored to domestic market requirements. Exact timelines can be confirmed upon order placement, ensuring prompt supply to meet your needs.
Q: Where can I access the certificate of analysis or the structural formula?
A: The certificate of analysis, including the detailed structural formula for Ranitidine HCL IP, is supplied with each batch or available upon request from the manufacturer or distributor.
Q: What is the packaging specification for Ranitidine HCL IP shipments?
A: Each shipment is packaged in a 25 kg fibre drum with double polythene inner bags to provide optimum protection against moisture and physical hazards during transit and storage.
Q: How does Ranitidine HCL IP benefit pharmaceutical manufacturers?
A: Its extraordinary purity, compliance with IP standards, and consistent particle size make it highly reliable for pharmaceutical formulation, ensuring high-quality and safe finished products.